☆ 4.7 Article

An Expert Opinion From the European Society of Hypertension-European Union Geriatric Medicine Society Working Group on the Management of Hypertension in Very Old, Frail Subjects

HYPERTENSION (2016)

Get Full Text
Add to Collection

Journal

HYPERTENSION
Volume 67, Issue 5, Pages 820-825

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/HYPERTENSIONAHA.115.07020

Keywords

-

Categories

Peripheral Vascular Disease

Funding

  1. Novartis
  2. Fukuda
  3. Servier
  4. Menarini International
  5. Recordati International
  6. Sanofi Aventis
  7. DOC generici
  8. Abbott
  9. Adamed
  10. Sanofi
  11. Amgen
  12. AstraZeneca
  13. Pfizer
  14. Orion
  15. Bayer
  16. Boehringer-Ingelheim
  17. Nutricia
  18. Actavis
  19. Covidien
  20. CVRx
  21. Daichi Sankyo
  22. Ferrer
  23. Lilly
  24. Medtronic Vascular Inc
  25. Merck Serono
  26. MSD
  27. Recordati
  28. Takeda
  29. Menarini Int.

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.